Scilex (SCLX) P/S (2022 - 2026)
Scilex (SCLX) P/S from Mar 31, 2022 to Jul 21, 2026. The TTM Scilex (SCLX) P/S is 1.97. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Scilex (SCLX)
| Year | P/S | Change |
|---|---|---|
| 2026 | 1.97 | +11.32% |
| 2025 | 1.77 | +27.92% |
| 2024 | 1.38 | -67.53% |
| 2023 | 4.25 | -76.95% |
| 2022 | 18.45 | N/A |
Comparison Scilex (SCLX) P/S with competitors
Scilex (SCLX) P/S is 1.97.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -70.75% |
| NVO | Novo Nordisk | 0.66 | -66.33% |
| GRFS | Grifols SA | 0.67 | -65.87% |
| AMRN | Amarin Corp | 1.39 | -29.30% |
| SNY | Sanofi | 2.18 | +11.03% |
| PFE | Pfizer Inc | 2.18 | +11.03% |
| BMY | Bristol-Myers Squibb Company | 2.40 | +22.02% |
| BIIB | Biogen Inc | 2.93 | +49.03% |
| GSK | GSK Plc | 3.22 | +63.98% |
| MRK | Merck & Co Inc | 4.54 | +130.71% |
| AZN | Astrazeneca plc | 4.58 | +133.20% |
| NVS | Novartis AG | 5.07 | +157.87% |
| AMGN | AMGEN Inc | 5.15 | +161.94% |
| GILD | Gilead Sciences Inc | 5.43 | +176.18% |
| JNJ | Johnson & Johnson | 6.34 | +222.47% |
| ABBV | Abbvie Inc | 7.15 | +263.67% |
| LLY | Lilly(Eli) & Company | 14.28 | +626.32% |